MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44.
J Pak Med Assoc. 2017 Oct;67(10):1524-1531
Authors: Chen J, Hongting L, Shaoping L, Xin C, Qian D
Abstract OBJECTIVE: To verify whether micro ribonucleic acid 34-a can exert its negative effects in human neuroblastoma cells. METHODS: The study was conducted at The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China during 15 months (from March 2015 to about June 2016).